Cerdulatinib (PRT062070)
CAS: 1369761-01-2
Ref. 3D-UEC76101
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Product Information
Cerdulatinib is a small molecule that inhibits the activity of the IL-2 receptor. It has been shown to be active against t-cell lymphomas and other cancers such as prostate cancer, breast cancer, and lung cancer. Cerdulatinib inhibits the transcriptional activation of survivin, an anti-apoptotic protein, which may lead to cell death in some cancers. The mechanism of action of cerdulatinib is not well understood, but it has been shown to inhibit nuclear DNA synthesis by binding to nuclear dna and inhibiting cell lysis. Cerdulatinib also has structural similarities with cyclosporine A (CsA), a drug used for transplant rejection. This drug is being studied as a possible treatment for humans with hematopoietic diseases or organ transplant rejection.br>br>
Chemical properties
Technical inquiry about: 3D-UEC76101 Cerdulatinib (PRT062070)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.